Bill
Bill > HB1852
TN HB1852
TN HB1852AN ACT to amend Tennessee Code Annotated, Title 33; Title 37; Title 44; Title 47; Title 49; Title 53; Title 63 and Title 68, relative to health.
summary
Introduced
01/21/2026
01/21/2026
In Committee
02/02/2026
02/02/2026
Crossed Over
Passed
Dead
Introduced Session
114th General Assembly
Bill Summary
As introduced, enacts the "Tennessee mRNA Pharmaceutical Sovereignty and Safety Act," which prohibits individuals, including professional providers of health care and veterinary medicine, from administering any vaccine or other injectable solution that contains an mRNA vaccine or vaccine material. - Amends TCA Title 33; Title 37; Title 44; Title 47; Title 49; Title 53; Title 63 and Title 68.
AI Summary
This bill, known as the "Tennessee mRNA Pharmaceutical Sovereignty and Safety Act," prohibits any individual, including healthcare professionals and veterinarians, from administering any vaccine or injectable solution containing mRNA (messenger ribonucleic acid) vaccine or vaccine material, which is a substance designed to stimulate antibody production against disease by introducing mRNA that codes for a viral protein, and also includes self-amplifying mRNA (samRNA) vaccines. Violating this prohibition is a Class A misdemeanor, punishable by a fine of up to $2,500 per violation, and healthcare providers may also face disciplinary action from their licensing boards, potentially leading to license revocation. The act amends various Tennessee Code Annotated titles related to health and takes effect on January 1, 2027.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Assigned to s/c Population Health Subcommittee (on 02/02/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://wapp.capitol.tn.gov/apps/Billinfo/default.aspx?BillNumber=HB1852&ga=114 |
| BillText | https://www.capitol.tn.gov/Bills/114/Bill/HB1852.pdf |
Loading...